• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.22% Nasdaq Up1.02%

    Cellular Biomedicine Group Inc. (CBMG)

    -NasdaqGM
    11.95 Up 0.65(5.75%) 2:11PM EDT - Nasdaq Real Time Price
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue 2,505   564   205  
    Cost of Revenue1,880  242  296  
    Gross Profit 625   322   (91)
    Operating Expenses
    Research Development7,573  3,146  2,042  
    Selling General and Administrative13,777  8,190  9,220  
    Non Recurring123  1,428   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (20,849) (12,442) (11,354)
    Income from Continuing Operations
    Total Other Income/Expenses Net673  87  (5)
    Earnings Before Interest And Taxes(20,176)(12,355)(11,359)
    Interest Expense -   -   -  
    Income Before Tax(20,176)(12,355)(11,359)
    Income Tax Expense(729) -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(19,448)(12,355)(11,359)
    Non-recurring Events
    Discontinued Operations -  (3,119)(2,439)
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (19,448) (15,475) (13,797)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (19,448) (15,475) (13,797)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.